Current evidence on screening for renal cancer
Nature Reviews Urology, Published online: 28 August 2020; doi:10.1038/s41585-020-0363-3Renal cell carcinoma (RCC) incidence is increasing worldwide. Here, the authors consider the potential benefits and harms of screening for RCC and discuss whether enough evidence is available to begin a clinical trial of RCC screening.
Source: Nature Reviews Urology - Category: Urology & Nephrology Authors: Juliet Usher-Smith Rebecca K. Simmons Sabrina H. Rossi Grant D. Stewart Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Clinical Trials | Grants | Kidney Cancer | Urology & Nephrology